Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Retinoic acids temporarily change skin stem cells to a slower cycle and more differentiated state.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

RORA plays a key role in controlling seasonal hair molting by affecting hair follicle cell activity.

Oral Acitretin effectively resolved symptoms in a child with Netherton syndrome.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

An 11-year-old girl with a rare skin disorder also had cornea issues and dry eye, needing careful management.

New psoriasis treatments are effective but come with side effects and risks.

Tranexamic acid and oral retinoids may effectively treat lichen plan pigmentosus.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Topical retinoids effectively improve photodamaged skin.

Ritlecitinib effectively regrows hair in severe alopecia areata, especially in adolescents.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Ritlecitinib shows promise in improving severe alopecia areata, with 27% of patients seeing success.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

The combination of tretinoin, minoxidil, and betamethasone valerate may cause severe scalp inflammation.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

Dermatologists need more training on isotretinoin's eye side effects.